Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.
Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodríguez-Mañas L, Fried LP, Woo J, Aprahamian I, Sanford A, Lundy J, Landi F, Beilby J, Martin FC, Bauer JM, Ferrucci L, Merchant RA, Dong B, Arai H, Hoogendijk EO, Won CW, Abbatecola A, Cederholm T, Strandberg T, Gutiérrez Robledo LM, Flicker L, Bhasin S, Aubertin-Leheudre M, Bischoff-Ferrari HA, Guralnik JM, Muscedere J, Pahor M, Ruiz J, Negm AM, Reginster JY, Waters DL, Vellas B. · 2019
Read Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. by Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodríguez-Mañas L, Fried LP, Woo J, Aprahamian I, Sanford A, Lundy J, Landi F, Beilby J, Martin FC, Bauer JM, Ferrucci L, Merchant RA, Dong B, Arai H, Hoogendijk EO, Won CW, Abbatecola A, Cederholm T, Strandberg T, Gutiérrez Robledo LM, Flicker L, Bhasin S, Aubertin-Leheudre M, Bischoff-Ferrari HA, Guralnik JM, Muscedere J, Pahor M, Ruiz J, Negm AM, Reginster JY, Waters DL, Vellas B. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6800406.txt.
Introduction
Dent and co-authors present international clinical practice guidelines for identifying and managing physical frailty in older adults. An expert task force from the International Conference of Frailty and Sarcopenia Research wrote them. They used the GRADE method to rate evidence strength behind each recommendation. Where evidence was thin, consensus-based recommendations filled the gap.
All older adults should be screened for frailty with a validated tool suited to the setting, a strong recommendation. Positive screens should trigger a fuller clinical assessment. Care plans must address polypharmacy and other drivers. Multi-component exercise, mixing resistance, aerobic, and balance training, improved strength, balance, disability, and falls in frail elders. The guidelines stress person-centered care throughout.
Catalog record
| CREATOR | Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodríguez-Mañas L, Fried LP, Woo J, Aprahamian I, Sanford A, Lundy J, Landi F, Beilby J, Martin FC, Bauer JM, Ferrucci L, Merchant RA, Dong B, Arai H, Hoogendijk EO, Won CW, Abbatecola A, Cederholm T, Strandberg T, Gutiérrez Robledo LM, Flicker L, Bhasin S, Aubertin-Leheudre M, Bischoff-Ferrari HA, Guralnik JM, Muscedere J, Pahor M, Ruiz J, Negm AM, Reginster JY, Waters DL, Vellas B. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management By E. Dent, J.E. Morley, A.J. Cruz-Jentoft, L. Woodhouse, L. Rodríguez-Mañas, L.P. Fried, J. Woo, I. Aprahamian, A. Sanford, J. Lundy, F. Landi, J. Beilby Published in: The Journal of Nutrition, Health & Aging DOI: 10.1007/s12603-019-1273-z ABSTRACT Objective The task force of the International Conference of Frailty and Sarcopenia Research (ICFSR) developed these clinical practice guidelines to overview the current evidence-base and to provide recommendations for the identification and management of frailty in older adults. Methods These recommendations were formed using the GRADE approach, which ranked the strength and certainty (quality) of the supporting evidence behind each recommendation. Where the evidence-base was limited or of low quality, Consensus Based Recommendations (CBRs) were formulated. The recommendations focus on the clinical and practical aspects of care for older people with frailty, and promote person-centred care. Recommendations for Screening and Assessment The task force recommends that health practitioners case identify/screen all older adults for frailty using a validated instrument suitable for the specific setting or context (strong recommendation). Ideally, the screening instrument should exclude disability as part of the screening process. For individuals screened as positive for frailty, a more comprehensive clinical assessment should be performed to identify signs and underlying mechanisms of frailty (strong recommendation). Recommendations for Management A comprehensive care plan for frailty should address polypharmacy (whether rational or nonrational), the management of sarcopenia, the treatable causes of weight loss, and the causes of exhaustion (depression, anaemia, hypotension, hypothyroidism, and B12 deficiency) (strong recommendation). All persons with frailty should receive social support as needed to address unmet needs and encourage adherence to a comprehensive care plan (strong recommendation). First-line therapy for the management of frailty should include a multi-component physical activity programme with a resistance-based training component (strong recommendation). Protein/caloric supplementation is recommended when weight loss or undernutrition are present (conditional recommendation). No recommendation was given for systematic additional therapies such as cognitive therapy, problem-solving therapy, vitamin D supplementation, and hormone-based treatment. Pharmacological treatment as presently available is not recommended therapy for the treatment of frailty. RECOMMENDATIONS Table 1Summary of ICFSR evidence-based recommendations and clinical considerations for the identification and management of frailty in older adultsRecommendationGradeCertainty of EvidenceFrailty Screening1All adults aged 65 years and over should be offered screening for frailty using a validated rapid frailty instrument suitable to the specific setting or contextStrongLowFrailty Assessment2Clinical assessment of frailty should be performed for all older adults screening as positive for frailty or pre-frailtyStrongLowDevelopment of a Comprehensive Management Plan3A comprehensive care plan for frailty should systematically address polypharmacy, the management of sarcopenia, treatable causes of weight loss, and the causes of fatigue (depression, anaemia, hypotension, hypothyroidism, and vitamin B12 deficiency)StrongVery Low4Where appropriate, persons with advanced (severe) frailty should be referred to a geriatricianCBRNo data†Physical Activity/Exercise5Older people with frailty should be offered a multi-component physical activity programme (or those with pre-frailty as a preventative component)StrongModerate6Health practitioners are strongly encouraged to refer older people with frailty to physical activity programmes with a progressive, resistance-training componentStrongModerateNutrition and Oral Health7Protein/caloric supplementation can be considered for persons with frailty when weight loss or undernutrition has been diagnosedConditionalVery Low8Health practitioners may offer nutritional/protein supplementation paired with physical activity prescriptionConditionalLow9Advise older adults with frailty about the importance of oral healthCBRNo data†Pharmacological Intervention10Pharmacological treatment as presently available is not recommended therapy for the treatment of frailtyCBRVery LowAdditional Therapies and Treatments11Vitamin D supplementation is not recommended for the treatment of frailty unless vitamin D deficiency is presentCBRVery low12Cognitive or problem-solving therapy is not systematically recommended for the treatment of frailtyCBRVery low13Hormone therapy is not recommended for the treatment of frailtyCBRVery low14All persons with frailty may be offered social support as needed to address unmet needs and encourage adherence to the Comprehensive Management PlanStrongVery low15Persons with frailty can be referred to home-based trainingConditionalLowWhere sufficient evidence was available from systematic reviews/meta-analyses, recommendations were ranked according to the GRADE approach (1). Where evidence was limited in systematic reviews/meta-analyses or for topics beyond the scope of systematic reviews, Consensus Based Recommendations (CBR) were formulated by the International Conference of Frailty and Sarcopenia Research (ICFSR) task force on frailty; † ‘No data' indicates no data identified by systematic reviews. INTRODUCTION Frailty is prevalent in all countries and is a leading contributor to functional decline and early mortality in older adults (2, 3, 4). The condition is defined as “a clinical state in which there is an increase in an individual's vulnerability for developing an increased dependency and/or mortality when exposed to a stressor” (5). Frailty can begin before 65 years of age, but the onset escalates in those aged 70 years and over (6). Nonetheless, frailty is not an obligatory part of the ageing process, and many adults reach advanced ages without developing frailty (7). Accordingly, various long-term risk factors of frailty, like overweight/obesity (8, 9), physical inactivity (10), cardiovascular risk (11, 12), self-rated health (13), and alcohol use (14) have been identified. The current estimate of physical frailty prevalence is around 15% for adults aged 65 years and over, based on a recent meta-analysis of community-dwelling older Europeans (15). In adults aged over 85 years, prevalence increases to over 25%. (16) Frailty prevalence is also elevated in persons with lower education, low socioeconomic position, or from ethnic minority groups (17, 18, 19, 20). In addition, women tend to have a higher prevalence of frailty than men (6, 16, 20, 21, 22, 23), although they may be more resistant to decline in frailty status over time (24). The number of older adults with frailty is increasing, likely due to increased survival of older adults with co-morbidities, more exposure to sedentary lifestyles, and smaller social support networks (25, 26, 27). There is much potential for frailty to be reversed, particularly in its early stages (28, 29, 30). For that reason, early identification and management of frailty is an important priority for both healthcare providers and healthcare policy makers (31, 32, 33). This paper presents international Clinical Practice Guidelines (CPGs) for the identification and management of frailty. Guideline Objectives These CPGs (hereafter known as “guidelines”) were developed to help ensure that all older people living with frailty are provided with high-quality, evidence-based care. The target audience for these guidelines includes all health professionals who contribute to the care of older people with frailty, including clinicians and allied health professionals; the target patient population includes all older adults with either frailty or at risk of frailty. These guidelines are not targeted towards those persons who already have well-established disability. The guidelines are applicable to both the hospital and primary care setting. It is expected that implementation of these CPGs will improve both the short- and long-term outcomes of older adults with frailty. The guidelines aim to maintain or improve the physical function, health and experience of the care process for older people with frailty. Continuity of care is encouraged. An outline of current, relevant evidence will be provided regarding screening, assessment and management of frailty in older adults. Health practitioners will use these guidelines differently depending on their care setting and expertise. It is anticipated that national, state and local policy makers will be able to utilise these guidelines to develop health, social and aged care policies specific for